AGEN
AGENUS INC
NASDAQ · Healthcare · Biotechnology · US
$6.18
+2.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 22.89x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.28x
- PEG TTM
- —
- Price / book
- -1.40x
- Price / sales
- 2.10x
- Price / cash flow
- -2.83x
Enterprise value
- Enterprise value
- $294.3M
- EV / sales
- 2.22x
- EV / EBITDA
- 1.89x
- EV / EBIT
- 8.13x
- Market cap
- $279.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026